Association between the CD14 gene C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 10, 2012, Pages 1383-1387

  Alavi Naini, R ^a   Salimi, Saeedeh ^b,c   Sharifi Mood, B ^a   Davoodikia, A A ^a   Moody, B ^b   Naghavi, A ^b  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ELISA; Mycobacterium tuberculosis; T ARMS PCR; TT genotype

Indexed keywords

CD14 ANTIGEN; SOLUBLE CD14 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ALLELE; AMPLIFICATION REFRACTORY MUTATION SYSTEM POLYMERASE CHAIN REACTION; ARTICLE; BACTERIAL GENE; BLOOD LEVEL; CASE CONTROL STUDY; CD14 GENE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INFECTION RISK; IRANIAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; SOLUBLE CD14 ANTIGEN BLOOD LEVEL;

ANTIGENS, CD14; BIOLOGICAL MARKERS; DNA; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; RETROSPECTIVE STUDIES; TUBERCULOSIS, PULMONARY;

EID: 84866463831     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0827     Document Type: Article

References (30)

1. World Health Organization. Global tuberculosis control: report. WHO/HTM/TB/2010.7. Geneva, Switzerland: WHO, 2010.
2. Centers for Disease Control and Prevention. Reported tuberculosis in Sistan and Balouchestan, Iran. Atlanta, GA, USA: CDC, 2009.
3. Comstock G W. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978; 117: 621-624. (Pubitemid 8334970)
4. Sorensen T I, Nielsen G G, Andersen P K, Teasdale T W. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318: 727-732. (Pubitemid 18090256)
5. Bellamy R. Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun 2003; 4: 4-11. (Pubitemid 38967569)
6. Bellamy R, Ruwende C, Corrah T, McAdam K P, Whittle H C, Hill A V. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. New Engl J Med 1998; 338: 640-644. (Pubitemid 28108433)
7. Bellamy R, Ruwende C, Corrah T, McAdam K P, Whittle H C, Hill A V. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tubercle Lung Dis 1998; 79: 83-89. (Pubitemid 29078276)
8. Akahoshi M, Nakashima H, Miyake K, et al. Influence of interleukin-12 receptor beta1 polymorphisms on tuberculosis. Hum Genet 2003; 112: 237-243. (Pubitemid 36869080)
9. Selvaraj P, Sriram U, Mathan Kurian S, Reetha A M, Narayanan P R. Tumour necrosis factor alpha (-238 and -308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes. Tuberculosis 2001; 81: 335-341. (Pubitemid 34087863)
10. Bellamy R, Ruwende C, Corrah T, et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179: 721-724. (Pubitemid 30016163)
11. Rosas-Taraco A G, Revol A, Salinas-Carmona M C, Rendon A, Caballero-Olin G, Arce-Mendoza A Y. CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis. J Infect Dis 2007; 196: 1698-1706. (Pubitemid 351411970)
12. Wright S D, Ramos R A, Tobias P S, Ulevitch R J, Mathison J C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein [Comment]. Science 1990; 249: 1431-1433.
13. Peterson P K, Gekker G, Hu S, et al. CD14 Receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect Immun 1995; 63: 1598-1602.
14. LeVan T D, Bloom J W, Bailey T J, et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001; 167: 5838-5844. (Pubitemid 33062776)
15. Zhao D, Sun T, Zhang X, et al. Role of CD14 promoter polymorphisms in Helicobacter pylori infection-related gastric carcinoma. Clin Cancer Res 2007; 13: 2362-2368. (Pubitemid 46698585)
16. Kang Y A, Lee H W, Kim Y W, Han S K, Shim Y S, Yim J J. Association between the -159C/T CD14 gene polymorphism and tuberculosis in a Korean population. FEMS Immunol Med Microbiol 2009; 57: 229-235.
17. Chao Y C, Chu H C, Chang W K, Huang H H, Hsieh T Y. CD14 promoter polymorphism in Chinese alcoholic patients with cirrhosis of liver and acute pancreatitis. World J Gastroenterol 2005; 11: 6043-6048.
18. Ulevitch R J, Tobias P S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995; 13: 437-457.
19. Pugin J, Heumann I D, Tomasz A, et al. CD14 is a pattern recognition receptor. Immunity 1994; 1: 509-516.
20. Bazil V, Baudys M, Hilgert I, et al. Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol Immunol 1989; 26: 657-662. (Pubitemid 19188482)
21. Bazil V, Strominger J L. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J I mmunol 1991; 147: 1567-1574.
22. Baldini M, Lohman I C, Halonen M, et al. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20: 976-983. (Pubitemid 129540855)
23. Hubacek J A, Rothe G, Pit'ha J, et al. C(-260)CT poly morphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999; 99: 3218-3220. (Pubitemid 29293428)
24. Yoon H J, Shin J H, Yang S H, et al. Association of the CD14 gene -159C polymorphism with progression of IgA nephropathy. J Med Genet 2003; 40: 104-108. (Pubitemid 36232814)
25. Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med 2002; 30: 969-973. (Pubitemid 34508015)
26. Brettschneider J, Ecker D, Bitsch A, et al. The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b. J Neuroimmunol 2002; 133: 193-197. (Pubitemid 35346741)
27. Pacheco E, Fonseca C, Montes C, Zabaleta J, García L F, Arias M A. CD14 gene promoter polymorphism in different clinical forms of tuberculosis. FEMS Immunol Med Microbiol 2004; 40: 207-213. (Pubitemid 38368184)
28. Eng H L, Wang C H, Chen C H, Chou M H, Cheng C T, Lin T M. A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNF alpha production. Genes Immun 2004; 5: 426-430. (Pubitemid 39139771)
29. Druszczyńska M, Strapagiel D, Kwiatkowska S, et al. Tuberculosis bacilli still posing a threat. Polymorphism of genes regulating anti-mycobacterial properties of macrophages. Pol J Microbiol 2006; 55: 7-12.
30. Peterson P K, Gekker G, Hu S, et al. CD14 receptor-mediated uptake of non-opsonized Mycobacterium tuberculosis by human microglia. Infect Immun 1995; 63: 1598-1602.